American International Group’s ClearPoint Neuro CLPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-11,298
Closed -$76.8K 555
2024
Q1
$76.8K Sell
11,298
-96
-0.8% -$671 ﹤0.01% 2651
2023
Q4
$77.4K Sell
11,394
-47
-0.4% -$266 ﹤0.01% 2688
2023
Q3
$57.3K Buy
11,441
+408
+4% +$2.43K ﹤0.01% 2780
2023
Q2
$79.9K Buy
+11,033
New +$93.8K ﹤0.01% 2714
2022
Q2
Sell
-9,455
Closed -$98K 3123
2022
Q1
$98K Sell
9,455
-666
-7% -$6.06K ﹤0.01% 2605
2021
Q4
$114K Sell
10,121
-302
-3% -$4.52K ﹤0.01% 2660
2021
Q3
$185K Sell
10,423
-121
-1% -$2.27K ﹤0.01% 2473
2021
Q2
$201 Buy
+10,544
New +$204K ﹤0.01% 2500

Other funds holding CLPT

American International Group's CLPT Position: Q2 2024 in Review

American International Group sold out of ClearPoint Neuro (CLPT) in Q2 2024, closing a stake of 11,298 shares — an estimated $76.8K sold.

American International Group first reported a position in CLPT in Q2 2021 and held it in 8 quarters. The position peaked at $185K in Q3 2021. 86 funds tracked by Wall St. Rank hold CLPT as of Q2 2024.

  • American International Group reported no remaining ClearPoint Neuro position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 11,298 ClearPoint Neuro shares in Q2 2024, an estimated $76.8K.
  • American International Group first reported a position in ClearPoint Neuro in Q2 2021 and held it in 8 quarters.
  • American International Group's ClearPoint Neuro position peaked at $185K in Q3 2021.
  • 86 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.